Brief: Outlook Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
BRIEF-Outlook Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants Aug 12 (Reuters) - Outlook Therapeutics Inc OTLK.O:
OUTLOOK THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND WARRANTS
OUTLOOK THERAPEUTICS - PROCEEDS TO SUPPORT LYTENAVA U.S. LAUNCH, WORKING CAPITAL, AND CORPORATE PURPOSES
Source text: ID:nGNX8zx3MT
Further company coverage: OTLK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce